Prime

Type your tag names separated by a space and hit enter

Micronuclei induction by carboplatin in human lymphocyte subpopulations.

Abstract

Micronuclei (MN) induction by carboplatin, cis-diammine-1,1-cyclobutane decarboxylate platinum (II) (CBDCA), in B and T lymphocytes was studied by the MAC (morphology/antibody/chromosome) method which allows the immunologic identification of different cell lineages. An increased frequency of MN in B and T lymphocytes in CBDCA-treated cultures compared with controls was observed (p < 0.001). CBD cells were found to be more sensitive to CBDCA damage. CBDCA-treated cultures showed a decrease, albeit statistically non-significant, in the proportion of CBD interphasic and mitotic cells. Furthermore, higher MN frequencies in isolated lymphocytes than in whole blood in both control and CBDCA-treated cultures were observed.

Links

  • Aggregator Full Text
  • Authors

    , , ,

    Source

    Anti-cancer drugs 6:6 1995 Dec pg 758-62

    MeSH

    Adult
    Antineoplastic Agents
    B-Lymphocytes
    Carboplatin
    Cells, Cultured
    Humans
    Immunoenzyme Techniques
    Lymphocytes
    Male
    Micronuclei, Chromosome-Defective
    Micronucleus Tests
    Middle Aged
    Mitosis
    T-Lymphocytes

    Pub Type(s)

    In Vitro
    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    8845488

    Citation

    TY - JOUR T1 - Micronuclei induction by carboplatin in human lymphocyte subpopulations. AU - Slavutsky,I, AU - Campos,E, AU - Cid,M G, AU - Larripa,I, PY - 1995/12/1/pubmed PY - 1995/12/1/medline PY - 1995/12/1/entrez SP - 758 EP - 62 JF - Anti-cancer drugs JO - Anticancer Drugs VL - 6 IS - 6 N2 - Micronuclei (MN) induction by carboplatin, cis-diammine-1,1-cyclobutane decarboxylate platinum (II) (CBDCA), in B and T lymphocytes was studied by the MAC (morphology/antibody/chromosome) method which allows the immunologic identification of different cell lineages. An increased frequency of MN in B and T lymphocytes in CBDCA-treated cultures compared with controls was observed (p < 0.001). CBD cells were found to be more sensitive to CBDCA damage. CBDCA-treated cultures showed a decrease, albeit statistically non-significant, in the proportion of CBD interphasic and mitotic cells. Furthermore, higher MN frequencies in isolated lymphocytes than in whole blood in both control and CBDCA-treated cultures were observed. SN - 0959-4973 UR - https://www.unboundmedicine.com/medline/citation/8845488/Micronuclei_induction_by_carboplatin_in_human_lymphocyte_subpopulations_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=linkout&amp;SEARCH=8845488.ui ER -